INHERIT: Discovering the Origin of Lung Cancer in Families
To further understand the genetic causes of certain types of lung cancer in families, GO2 for Lung Cancer is collaborating with the Dana-Farber Cancer Institute, and the Addario Lung Cancer Medical Institute (ALCMI), GO2's medical consortium, on INHERIT.
INHERIT builds on a previous study that identified an inherited gene mutation for lung cancer. It will look more deeply into families' genetic makeup to identify other mutations that increase the risk for lung cancer to inform prevention and treatment.
Watch this webinar to learn more about the difference between germline (inherited) and somatic (acquired) mutations that can lead to lung cancer and the INHERIT Study, which is currently enrolling to investigate the inherited risk for lung cancer development.
